Top Markets
Coin of the day
Taysha Gene Therapies, Inc. Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc.

TSHA
Rang în acțiuni #6654
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and... Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome; TSHA-121 and TSHA-118 are both being advanced for CLN1 disease; TSHA-105 addresses SLC13A5 Deficiency; and TSHA-101 targets GM2 gangliosidosis. Furthermore, Taysha has forged a strategic alliance with The University of Texas Southwestern Medical Center to jointly advance and bring to market innovative gene therapy solutions. Founded in 2019, the company operates from its headquarters in Dallas, Texas.
Preț acțiune
$6.02
Ultima sincronizare: 2026-08-27
Capitalizare de piață
$1.93B
Schimbare (1 zi)
0.00%
Schimbare (1 an)
112.72%
Țară
US
Tranzacționează Taysha Gene Therapies, Inc. (TSHA)

Categorie

Istoric al prețului acțiunii pentru Taysha Gene Therapies, Inc. (TSHA)
Cel mai mare preț de închidere: $6.22 pe 2026-08-01

Cel mai mic preț de închidere: $23.52 pe 2020-09-01
Istoric al prețului acțiunii pentru Taysha Gene Therapies, Inc. din 2020 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) -5.89%
2025 151.61%
2024 28.42%
2023 -21.84%
2022 -83.88%
2021 -42.11%
2020 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$548.36 39.87%
US
$1.06K 50.29%
NL
$122.42 -11.85%
AU
$140.81 475.44%
US
$765.25 7.74%
CH